Abstract
AbstractRaynaud’s syndrome is a common dysautonomia where exposure to cold increases the vascular tone of distal arteries causing vasoconstriction and hypoxia, particularly in the extremities. Current treatment options are limited and unspecific. Biological mechanisms leading to the phenotype remain uncharacterized. Using genetic and electronic health record data from the UK Biobank, the Mass-General Brigham Biobank, the Estonian Biobank, and the FinnGen study, we identified 11,358 individuals with a diagnosis of Raynaud’s syndrome and 1,106,871 population controls. We found eight loci including endothelial nitric oxide synthase (NOS3), HLA, and a notable association at the α2A-adrenergic receptor (ADRA2A)locus (rs7090046, P = 3.93×10-47), implicating adrenergic signaling as a major risk factor with Raynaud’s syndrome. We further investigate the role of the variants andADRA2Aexpression in functional and physiological models.In silicofollow-up analysis revealed an expression quantitative trait locus (eQTL) that co-localized and increasedADRA2Agene expression in a tissue-specific manner in the distal arteries. Staining with RNA scope further clarified the specificity ofADRA2Aexpression in small vessels. We show by CRISPR gene editing that the SNP region modifiesADRA2Agene expression in pulmonary artery smooth muscle cells. Finally, we performed a functional contraction assay on smooth muscle cells in cold conditions and showed lower contraction inADRA2A-deficient and higher contraction inADRA2A-overexpressing smooth muscle cells. Our results indicate that Raynaud’s syndrome is related to vascular function mediated by adrenergic signaling throughADRA2A. Our study highlights the power of genome-wide association testing as a discovery tool for poorly understood clinical endpoints and further clarifies the role of adrenergic signaling in Raynaud’s syndrome by fine-mapping, usingin vitrogenomic manipulations and functional validation in distal smooth muscle cell populations located in arterioles
Publisher
Cold Spring Harbor Laboratory
Reference75 articles.
1. Dysautonomia in the Ehlers-Danlos syndromes and hypermobility spectrum disorders-With a focus on the postural tachycardia syndrome;Am. J. Med. Genet. C. Semin. Med. Genet,2021
2. Nawaz, I. , Nawaz, Y. , Nawaz, E. , Manan, M.R. & Mahmood, A . Raynaud’s Phenomenon: Reviewing the Pathophysiology and Management Strategies. Cureus 14(1), (2022).
3. Garner, R. , Kumari, R. , Lanyon, P. , Doherty, M. & Zhang, W . Prevalence, risk factors and associations of primary Raynaud’s phenomenon: systematic review and meta-analysis of observational studies. BMJ Open 5(3), (2015).
4. World Health Organization. (2004). ICD-10: international statistical classification of diseases and related health problems: tenth revision, 2nd ed. World Health Organization. https://apps.who.int/iris/handle/10665/42980
5. Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献